## Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with crohn's disease. ## Methods: Data were obtained from the pediatric inflammatory bowel disease (ibd) collaborative group registry, a prospective, multicenter observational registr
Perianal fistulae in Crohn's Disease: Current and future approaches to treatment
โ Scribed by Hussila Keshaw; Keen S. Foong; Alastair Forbes; Richard M. Day
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 128 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
โฆ Synopsis
Perianal fistulae are common in Crohn's disease but rarely heal without treatment. The main aim of treatment is to effectively close the fistula without affecting sphincter integrity and continence. Traditional surgical and medical approaches are not without their limitations and may result in either comorbidity, such as fecal incontinence, or incomplete healing of the fistulae. Over the last 2 decades these limitations have led to a paradigm shift toward the use of biomaterials, and more recently cell-based therapies, which have met with variable degrees of success. This review discusses the traditional and current methods of treatment, as well as emerging and possible alternative approaches that may improve fistula healing.
๐ SIMILAR VOLUMES
Background: Complex fistulas and persistent perineal sinuses as a result of perianal Crohn's disease remain a major therapeutic challenge. A muscle transposition may promote wound healing by filling the perineal cavity and increasing tissue oxygenation. We aimed to evaluate the outcomes of the treat
Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with